drugset / Trial / NCT05485558
the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims at investigating the possible efficacy and safety of N-acetyl cysteine as adjuvant therapy in the treatment of drug-resistant epilepsy
Timeline
- Start
- 2022-09-15
- Primary completion
- 2024-06-01
- Completion
- 2025-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 10 mg/kg | — |
| Comparator | N-acetylcysteine | Small molecule | 40 mg/kg | — |